1475008

Novobiocin

United States Pharmacopeia (USP) Reference Standard

Manufacturer: Sigma Aldrich

CAS Number: 56677-21-5

Synonym(S): Benzamide, N-[7-[[3-O-(aminocarbonyl)-6-deoxy-5-C-methyl-4-O-methyl-ß-l-lyxohexopyranosyl]oxy]-4-hydroxy-8-methyl-2-oxo-2H-1-benzopyran-3-yl]-4-hydroxy-3-

Select a Size

Pack Size SKU Availability Price
200 MG 1475008-200-MG In Stock ₹ 40,355.60

1475008 - 200 MG

₹ 40,355.60

In Stock

Quantity

1

Base Price: ₹ 40,355.60

GST (18%): ₹ 7,264.008

Total Price: ₹ 47,619.608

grade

pharmaceutical primary standard

API family

novobiocin

manufacturer/tradename

USP

application(s)

pharmaceutical (small molecule)

format

neat

storage temp.

−20°C

InChI

1S/C31H35N2O11.Na/c1-14(2)7-8-16-13-17(9-11-19(16)34)27(37)33-21-22(35)18-10-12-20(15(3)24(18)42-28(21)38)41-29-23(36)25(43-30(32)39)26(40-6)31(4,5)44-29;/h7,9-13,23,25-26,29,34,36H,8H2,1-6H3,(H2,32,39)(H,33,37);/q-1;+1

InChI key

AXOUUAINTJNFRS-UHFFFAOYSA-N

Other Options

Image Product Name Manufacturer Price Range
Sigma Aldrich Fine Chemicals Biosciences Novobiocin United States Pharmacopeia (USP) Reference Standard | 56677-21-5 | 200MG
-- ₹ 47,205.60
56677-21-5 | Novobiocin
-- ₹ 34,265.00

Related Products

Img

Sigma Aldrich

1609680

United States Pharmacopeia (USP) Re...

Img

Sigma Aldrich

1231604

United States Pharmacopeia (USP) Re...

Img

Sigma Aldrich

1286300

United States Pharmacopeia (USP) Re...

Img

Sigma Aldrich

1478367

United States Pharmacopeia (USP) Re...

Img

Sigma Aldrich

1547925

United States Pharmacopeia (USP) Re...

Img

Sigma Aldrich

1164697

United States Pharmacopeia (USP) Re...

Img

Sigma Aldrich

1535700

United States Pharmacopeia (USP) Re...

Img

Sigma Aldrich

1224981

United States Pharmacopeia (USP) Re...

Description

  • General description: This product is provided as delivered and specified by the issuing Pharmacopoeia. All information provided in support of this product, including SDS and any product information leaflets have been developed and issued under the Authority of the issuing Pharmacopoeia.For further information and support please go to the website of the issuing Pharmacopoeia.
  • Application: Enhancing antibiotic effectiveness: Novobiocin is explored as a co-agent in antibacterial strategies, particularly in enhancing the efficacy of other antibiotics like rifampicin against multidrug-resistant bacteria. This underscores its role in combating bacterial resistance and its potential application in developing new antibacterial therapies (Ramirez et al., 2024).Gene expression modulation: The study investigates novobiocin′s impact on gene expression related to antibiotic production, demonstrating its utility in biotechnological applications to boost the yield of other clinically important antibiotics. This research highlights its role in understanding and manipulating microbial pathways for enhanced drug production (Zhukrovska et al., 2024).Microbial metabolism in animal health: Novobiocin′s effects on microbial nitrogen metabolism in composted poultry litter are assessed, providing insights into its environmental and veterinary applications. This study illustrates its broader applications beyond human medicine, particularly in agricultural and environmental health (Arzola-Alvarez et al., 2022).
  • Analysis Note: These products are for test and assay use only. They are not meant for administration to humans or animals and cannot be used to diagnose, treat, or cure diseases of any kind.  ​
  • Other Notes: This product is part of the USP Biologics program.

SAFETY INFORMATION

Pictograms

GHS07

Signal Word

Warning

Hazard Statements

H302,H317

Precautionary Statements

P261 - P264 - P272 - P280 - P301 + P312 - P302 + P352

Hazard Classifications

Acute Tox. 4 Oral - Skin Sens. 1

WGK

WGK 3

Flash Point(F)

Not applicable

Flash Point(C)

Not applicable